Cargando…
Reply to Dorgham et al., “Considering Personalized Interferon Beta Therapy for COVID-19”
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Society for Microbiology
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8097451/ https://www.ncbi.nlm.nih.gov/pubmed/33558288 http://dx.doi.org/10.1128/AAC.00083-21 |
| _version_ | 1783688349306847232 |
|---|---|
| author | Davoudi-Monfared, Effat Khalili, Hossein |
| author_facet | Davoudi-Monfared, Effat Khalili, Hossein |
| author_sort | Davoudi-Monfared, Effat |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8097451 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | American Society for Microbiology |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-80974512021-05-10 Reply to Dorgham et al., “Considering Personalized Interferon Beta Therapy for COVID-19” Davoudi-Monfared, Effat Khalili, Hossein Antimicrob Agents Chemother Letter to the Editor American Society for Microbiology 2021-03-18 /pmc/articles/PMC8097451/ /pubmed/33558288 http://dx.doi.org/10.1128/AAC.00083-21 Text en Copyright © 2021 American Society for Microbiology. https://doi.org/10.1128/ASMCopyrightv1All Rights Reserved (https://doi.org/10.1128/ASMCopyrightv1) . |
| spellingShingle | Letter to the Editor Davoudi-Monfared, Effat Khalili, Hossein Reply to Dorgham et al., “Considering Personalized Interferon Beta Therapy for COVID-19” |
| title | Reply to Dorgham et al., “Considering Personalized Interferon Beta Therapy for COVID-19” |
| title_full | Reply to Dorgham et al., “Considering Personalized Interferon Beta Therapy for COVID-19” |
| title_fullStr | Reply to Dorgham et al., “Considering Personalized Interferon Beta Therapy for COVID-19” |
| title_full_unstemmed | Reply to Dorgham et al., “Considering Personalized Interferon Beta Therapy for COVID-19” |
| title_short | Reply to Dorgham et al., “Considering Personalized Interferon Beta Therapy for COVID-19” |
| title_sort | reply to dorgham et al., “considering personalized interferon beta therapy for covid-19” |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8097451/ https://www.ncbi.nlm.nih.gov/pubmed/33558288 http://dx.doi.org/10.1128/AAC.00083-21 |
| work_keys_str_mv | AT davoudimonfaredeffat replytodorghametalconsideringpersonalizedinterferonbetatherapyforcovid19 AT khalilihossein replytodorghametalconsideringpersonalizedinterferonbetatherapyforcovid19 |